DK0904285T3 - Cykliske adhæsionsinhibitorer - Google Patents

Cykliske adhæsionsinhibitorer

Info

Publication number
DK0904285T3
DK0904285T3 DK97917291T DK97917291T DK0904285T3 DK 0904285 T3 DK0904285 T3 DK 0904285T3 DK 97917291 T DK97917291 T DK 97917291T DK 97917291 T DK97917291 T DK 97917291T DK 0904285 T3 DK0904285 T3 DK 0904285T3
Authority
DK
Denmark
Prior art keywords
adhesion inhibitors
cyclic adhesion
cyclic
inhibitors
adhesion
Prior art date
Application number
DK97917291T
Other languages
Danish (da)
English (en)
Inventor
Alfred Jonczyk
Simon Goodman
Beate Diefenbach
Horst Kessler
Marcus Koppitz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0904285T3 publication Critical patent/DK0904285T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK97917291T 1996-04-06 1997-04-02 Cykliske adhæsionsinhibitorer DK0904285T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19613933A DE19613933A1 (de) 1996-04-06 1996-04-06 Cyclische Adhäsionsinhibitoren
PCT/EP1997/001657 WO1997038009A1 (de) 1996-04-06 1997-04-02 Cyclische adhäsionsinhibitoren

Publications (1)

Publication Number Publication Date
DK0904285T3 true DK0904285T3 (da) 2003-01-27

Family

ID=7790744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97917291T DK0904285T3 (da) 1996-04-06 1997-04-02 Cykliske adhæsionsinhibitorer

Country Status (24)

Country Link
US (1) US6127335A (cs)
EP (1) EP0904285B1 (cs)
JP (1) JP4115530B2 (cs)
KR (1) KR100438378B1 (cs)
CN (1) CN1119351C (cs)
AR (1) AR006523A1 (cs)
AT (1) ATE224402T1 (cs)
AU (1) AU717496B2 (cs)
BR (1) BR9708530A (cs)
CA (1) CA2250861C (cs)
CZ (1) CZ291510B6 (cs)
DE (2) DE19613933A1 (cs)
DK (1) DK0904285T3 (cs)
ES (1) ES2183159T3 (cs)
HU (1) HUP9903631A3 (cs)
NO (1) NO984667D0 (cs)
PL (1) PL187924B1 (cs)
PT (1) PT904285E (cs)
RU (1) RU2184121C2 (cs)
SK (1) SK283718B6 (cs)
TW (1) TW570929B (cs)
UA (1) UA61071C2 (cs)
WO (1) WO1997038009A1 (cs)
ZA (1) ZA972843B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69930764D1 (de) 1998-12-23 2006-05-18 G D Searle Llc St Louis Verwendung von cyclooxygenase-2 inhibitor celecoxib und capecitabine zur kombinationsbehandlung von neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6521593B1 (en) * 1999-02-01 2003-02-18 Childrens Hospital Los Angeles Methods for inhibiting brain tumor growth
UA71608C2 (en) 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
PL204102B1 (pl) 2000-11-01 2009-12-31 Merck Patent Gmbh Zastosowanie inhibitorów αvß₃ i/lub αvß₅ do otrzymywania leku do profilaktyki i/lub terapii chorób oczu.
US20040029788A1 (en) * 2000-11-01 2004-02-12 Hans-Markus Bender Methods and compositions for the treatment of diseases of the eye
JP4499327B2 (ja) * 2001-12-06 2010-07-07 松崎 浩巳 拡径器具および手術器具セット
WO2003075741A2 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
US20040001835A1 (en) * 2002-03-04 2004-01-01 Medimmune, Inc. Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
ES2337134T3 (es) 2002-03-12 2010-04-21 Bristol-Myers Squibb Company Derivados de c3-ciano-epotilona.
ITRM20020402A1 (it) * 2002-07-29 2004-01-29 Sigma Tau Ind Farmaceuti Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine.
US20040224986A1 (en) 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
CA2496127C (en) * 2002-08-16 2012-05-29 Janssen Pharmaceutica N.V. Piperidinyl compounds that selectively bind integrins
JP2006516635A (ja) * 2003-01-30 2006-07-06 メディミューン，インコーポレーテッド インテグリンαｖβ３アンタゴニストの使用
CN101990425B (zh) * 2008-04-08 2016-01-20 默克专利股份有限公司 包含环肽的组合物和使用方法
US10745444B2 (en) 2017-04-17 2020-08-18 National Tsing Hua University Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same
ES2904658T3 (es) * 2017-04-17 2022-04-05 Univ Nat Tsing Hua Método para preparar un ciclopéptido
US10494403B2 (en) 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077279A (zh) * 1992-04-09 1993-10-13 北京矿冶研究总院 雷管桥丝发火电阻安全检测仪
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren

Also Published As

Publication number Publication date
JP4115530B2 (ja) 2008-07-09
CN1119351C (zh) 2003-08-27
CZ291510B6 (cs) 2003-03-12
NO984667L (no) 1998-10-06
RU2184121C2 (ru) 2002-06-27
HUP9903631A3 (en) 2000-04-28
PL187924B1 (pl) 2004-11-30
AU2568897A (en) 1997-10-29
CA2250861A1 (en) 1997-10-16
DE19613933A1 (de) 1997-10-09
UA61071C2 (en) 2003-11-17
DE59708269D1 (de) 2002-10-24
EP0904285A1 (de) 1999-03-31
WO1997038009A1 (de) 1997-10-16
BR9708530A (pt) 1999-08-03
KR100438378B1 (ko) 2004-08-25
CZ320398A3 (cs) 1999-01-13
SK136498A3 (en) 1999-05-07
HUP9903631A2 (hu) 2000-03-28
ZA972843B (en) 1998-02-19
JP2000510102A (ja) 2000-08-08
SK283718B6 (sk) 2003-12-02
AU717496B2 (en) 2000-03-30
ES2183159T3 (es) 2003-03-16
CA2250861C (en) 2008-07-15
CN1218478A (zh) 1999-06-02
NO984667D0 (no) 1998-10-06
ATE224402T1 (de) 2002-10-15
PT904285E (pt) 2003-02-28
AR006523A1 (es) 1999-09-08
EP0904285B1 (de) 2002-09-18
US6127335A (en) 2000-10-03
TW570929B (en) 2004-01-11
PL329154A1 (en) 1999-03-15
KR20000005210A (ko) 2000-01-25

Similar Documents

Publication Publication Date Title
ATE189461T1 (de) Cyclische adhäsionsinhibitoren
DE69621026D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DE69637328D1 (de) Zelladhäsionsinhibitoren
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
IS2538B (is) Bakflæðishemlar
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DE59707990D1 (de) Adhäsive
DE59708269D1 (de) Cyclische adhäsionsinhibitoren
PT956294E (pt) Inibidores da trombina
DE69709833T2 (de) Wellenformentzerrer
ATE282629T1 (de) Thrombininhibitoren
DE69720957T2 (de) Ace-hemmer
PT948483E (pt) Inibidores da farnesil-transferase
BR9610514A (pt) Inibidores cicloantihelmínticos
SI0904285T1 (en) Cyclic adhesion inhibitors
KR970049480U (ko) 접착테이프용 첩부기
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β